Not exact matches
The medical insertion of mesh has been a regular procedure to
repair the muscle damage caused by conditions such as
pelvic organ prolapse (POP) or stress urinary incontinence (SUI), and is also commonly used for hernia mesh
repair surgeries.
Recently, the FDA made two proposals to tackle the risks involving surgical mesh and its use in transvaginal
repair to treat
pelvic organ prolapse.
FDA Public Health Notification: Serious Complications Associated with Transvaginal Placement of Surgical Mesh in
Repair of
Pelvic Organ Prolapse and Stress Urinary Incontinence, FDA, July 13, 2011
• 4.8 % experienced mesh erosion • 2.4 % experienced painful intercourse • 4 patients developed
pelvic abscesses • 7 patients experienced mesh shrinkage The US Food and Drug Administration says vaginal mesh erosion is the most common complication related to this device when used for
pelvic organ repair.
Women diagnosed with
pelvic organ prolapse or stress urinary incontinence may have transvaginal mesh devices implanted during surgery to
repair the damage.
FDA Denies Citizen Petition's Request to Ban Marketing of Non-Absorbable Surgical Mesh Products for Transvaginal
Repair of
Pelvic Organ Prolapse, Natlawreview.com, August 21, 2014
This Food and Drug Administration classification means that complications associated with transvaginal mesh are «not rare» and that there is no evidence proving that transvaginal mesh
repair surgeries for
pelvic organ prolapse (POP) are more effective than traditional non-mesh
repair.
The implanting transvaginal mesh devices was initially seen as an enhanced alternative to tradition surgery to
repair POP (
pelvic organ prolapse.)